Vancouver, BC (same PRWeb) January 25, 2012
Doctor says Kamran Zamanian, CEO of iData
total prostate cancer treatment device market to grow double-digit rate in the forecast period, with sales in the first robotic prostate EBRT driven capital equipment, is expected. Not only of prostate cancer prostate robotic growing but increasingly accepted by the urine, according to their clinical benefits compared with traditional methods.
Robotic prostate, however, has been growing at double digit rates and is expected to remain strong through 2018. In the market for treating prostate cancer, the da Vinci robotic prostate surgery, Intuitive their monopoly? Surgical system, variant Medical Systems and Siemens in the market is dominated by external radiation therapy, brachytherapy, and the market is dominated by CR Bard.
Additional
, while catheter market is set to continue double-digit growth through 2018 with Coloplast, CR Bard and Covidien is a struggle to dominate this sector.
Significant increase in doctors
occasional sales catheter can help to change by the Center for Medicare and Medicaid Services (CMS) for the repayment of intermittent urinary catheter, and the increasing demand for hydrophilic-coated catheters have been made, Zamanian. All these factors have caused the market to increase significantly in the last year intermittent urinary catheters .????
For more information, register for free iDatas website at: http://www.idataresearch.net/idata/registration.php
iDatas
Series 3 – Report: Markets for Urological Devices 2012 include the United States, Europe and Asia-Pacific and provides a comprehensive analysis of the device used to treat benign prostatic hyperplasia (BPH), prostate cancer, kidney and urinary incontinence stone, and as . Other markets include the analysis of bladder cancer, shining, urodynamic equipment and nephrostomy devices.
About iData Research
iData Research (http://www.idataresearch.net/idata/discoveridata.php) international market research and consulting group focused on providing market intelligence for the medical, dental, and pharmaceutical companies. iData Research considers the following: urology, endoscopy, laparoscopy, gynecology, health, and more ear, nose and throat.
Contact
:
Drew Gutschmidt
iData Research
probability (IN) idataresearch (DOT) net
# # # # #